Provided by Tiger Trade Technology Pte. Ltd.

CSPC PHARMA

9.815
-0.185-1.85%
Volume:33.87M
Turnover:333.85M
Market Cap:113.09B
PE:24.67
High:10.010
Open:10.000
Low:9.745
Close:10.000
52wk High:10.720
52wk Low:6.387
Shares:11.52B
HK Float Shares:11.52B
Volume Ratio:0.49
T/O Rate:0.29%
Dividend:0.29
Dividend Rate:2.95%
EPS(LYR):0.398
ROE:20.90%
ROA:10.70%
PB:2.57
PE(LYR):24.67
PS:3.08

Loading ...

CSPC Pharmaceutical Group Stock Rises 1.5% in Hong Kong, Underperforms Competitors

Dow Jones
·
Oct 06

CSPC Pharma to Present Updates from Eight Trials at European Oncology Conference

MT Newswires Live
·
Oct 05

CSPC Pharma to Present Eight Oncology Trial Updates, Including Two Late-Breaking Abstracts, at ESMO 2026

Bulletin Express
·
Oct 05

CSPC Pharma to Unveil Eight New Clinical Trial Advances at 2026 ESMO Congress

Stock News
·
Oct 05

CSPC PHARMA Maintains 11.52 Billion Shares Outstanding in September; 1.15 Billion Options Could Add 10% Dilution

Bulletin Express
·
Oct 02

Major Drugmakers Turn to China for Licensing Deals

Reuters
·
Oct 02

Movement Alert|CSPC PHARMA Falls 3.13% in Regular Trading, Trading at HK$9.735

Market Focus
·
Oct 02

CSPC Pharmaceutical Group (SEHK:1093) Could Be 26% Undervalued Following Three Phase III Updates

Simply Wall St.
·
Oct 01

CSPC Reports Blood Sugar Reduction in Phase III Diabetes Study

MT Newswires Live
·
Oct 01

CSPC Pharma Announces Positive Phase III Results for Weekly GLP-1 Candidate TG103 in Chinese Type 2 Diabetes Patients

Bulletin Express
·
Sep 30

CSPC Pharmaceutical (01093) Reveals Positive Phase III Results for Edaglutide Alfa Injection Combined with Metformin in Chinese Adults with Type 2 Diabetes at EASD 2026

Stock News
·
Sep 30

CSPC Pharmaceutical Group Stock Rallies 6.3% in Hong Kong, Outperforms Competitors

Dow Jones
·
Sep 30

AI Drug Discovery Sector Heats Up: ChinaAMC Hang Seng Biotech (03069) Rises Over 4% Intraday, ChinaAMC Innovative Drugs (03525) Gains Over 3% in Afternoon Session

Stock News
·
Sep 30

CSPC Pharma Shares Rise Nearly 6% on String of R&D Updates Spanning mRNA Cancer Vaccines and Recombinant Protein Vaccines

Stock News
·
Sep 30

CSPC Hits 5-Week High on US FDA's Nod on Herpes Zoster Vaccine Trial

Reuters
·
Sep 30

Movement Alert|CSPC PHARMA Rises 3.48% in Regular Trading, Herpes Zoster Vaccine Receives US FDA Clinical Trial Approval

Market Focus
·
Sep 30

CSPC Pharma Wins FDA Nod to Initiate U.S. Trials for First Recombinant Herpes Zoster Vaccine

Bulletin Express
·
Sep 29

CSPC Pharmaceutical Initiates Phase IB Clinical Trial of Jmt206 Injection in China

Reuters
·
Sep 29

CSPC Pharma's JMT206 Injection Ib Phase Trial for Weight Management in Overweight or Obese Adults Officially Launches at First Site in China

Stock News
·
Sep 29

CSPC Pharma's Recombinant Shingles Vaccine SYS 6052 Gains US Clinical Trial Approval

Stock News
·
Sep 29